Pharmaceutical companies

Product launch

Do we launch products or improve health?

IEXP helps pharmaceutical companies to the successful launch of therapies by gathering real world data and patient insights in order to determine with PROM, PREM and value indicators te real impact of a therapy in the lives of patients and their social environment. Key messages for prescriptor claims, as well as data for a smoother access help to a better prescription, improved adherence and shorter launch times.
IEXP takes care of all the value chain from patient recruiting through our hospital and patient association network (also in Europe and Brazil), qualitative research, quantitative research and artificial intelligence, scaling on platforms for international data gathering up to communication to different stakeholders in and outside the company.

Ask for information

Patient value

IEXP takes care of all the value chain from patient recruiting through our hospital and patient association network (also in Europe and Brazil), qualitative research, quantitative research and artificial intelligence, scaling on platforms for international data gathering up to communication to different stakeholders in and outside the company.
We work with many patient associations -especially in respiratory, oncological and neurological areas- and also with a high number of non associated patients through a network of hospital agreements.

Ask for information

Adherence

Are adherence rates of 40% to 50% medically responsible and economically sustainable?

We help improve therapeutic adherence with a participatory health approach, scientific evidence and use of real word evidence and real world data.

Ask for information

Clinical trials

Research paradigm focused on researchers or paradigm that includes the needs of key actors?

We contribute to the highest data quality, efficient use of technologies and reduction of drop out with a participatory action and health research approach according to internationally validated guides.

Ask for information

Complete outsourcing of the patient centricity service

In the new pharmaceutical scenarios, patient centricity is a key aspect in both clinical trials, as in the approval of therapies, as well as the improvement of adherence.

IEXP assumes the integral management of the patient centricity offering the following services in close collaboration with the access, medical, marketing and patient access areas:

  • Structuring: strategy, processes and protocols.
  • Patient journey from the patient's perspective.
  • Validated scales for therapy approval.
  • Patient-centered product launch and patient-centered prescription.
  • Patient-centered clinical trial.
  • Improvement of adherence.

Our differential value in practice

Market

Listening to patients and stakeholders in the ecosystem allows a complete view of market and customer needs.

Access

Aprobación cada vez más dependiente de PROMS y PREMS.

Cost

Protocolos mas eficientes y rentables.

Real World Evidence

Understand the complete context of the client: meaningful data.

Clinical results

Incorporation of indicators and validated scales.

Customers

Identify critical profiles and their needs.

Prescription

Patient-centered clinical prescription as an impact reinforcement to the prescription based on scientific evidence.

Lasting relationships

Create lasting and meaningful relationships with healthcare professionals, associations and other actors in the ecosystem.